The impact of abdominal obesity on the quality of life and the clinical and functional state of the musculoskeletal system in patients with osteoarthritis
pdf (Українська)

Keywords

osteoarthritis, Lequesne index, WOMAC index, abdominal obesity, VAS, EuroQol- 5D questionnaire.

How to Cite

Humeniuk, M., & Borushok, I. (2022). The impact of abdominal obesity on the quality of life and the clinical and functional state of the musculoskeletal system in patients with osteoarthritis. Therapeutics / Named After Prof. M.M. Berezhnytskyi, 3(2-3), 64-68. https://doi.org/10.31793/2709-7404.2022.3-2-3.64

Abstract

Introduction. Osteoarthritis (OA) is the most common joint disease affecting more than 240 million people worldwide and is the most common cause of activity limitation in adults. Objective. To determine the impact of abdominal obesity on the quality of life and the clinical and functional state of the musculoskeletal system in patients with osteoarthritis. Results. According to the examination results, it was determined that in patients with combined pathology, anthropometric data and BMI were significantly higher than in patients with isolated OA. By dividing the patients according to the radiological stage of OA, it was found that in the group of patients with OA without combined pathology, stage I and II prevailed, and stage IV was not detected in the corresponding group, while in the group of patients with OA combined with abdominal obesity stage III was mainly observed. Also, 12% of patients in this group had IV radiological stage of OA. Based on the obtained data, it was found that all quality of life indicators in patients with combined pathology were significantly increased compared to the group of patients with OA (p<0.05), which indicates an unsatisfactory level of quality of life in patients with OA with abdominal obesity. Conclusions. It was determined, that there is an increase in the severity and intensity of clinical symptoms (increase in VAS, Lequesne and WOMAC indices) and a lower quality of life in patients with OA in association with obesity compared to the isolated OA.

https://doi.org/10.31793/2709-7404.2022.3-2-3.64
pdf (Українська)

References

Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):3-6. Epub 2019 Oct 14. PMID: 31621562.

Katz JN, Arant KR, Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA. 2021 Feb 9;325(6):568-78. doi: 10.1001/jama.2020.22171. PMID: 33560326; PMCID: PMC8225295.

Bortoluzzi A, Furini F, Scirè CA. Osteoarthritis and its management — Epidemiology, nutritional aspects and environmental factors. Autoimmun Rev. 2018 Nov;17(11):1097-104. doi: 10.1016/j.autrev.2018.06.002. Epub 2018 Sep 11. PMID: 30213694.

Berenbaum F, Wallace IJ, Lieberman DE, Felson DT. Modern-day environmental factors in the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2018 Nov;14(11):674-81. doi: 10.1038/s41584-018-0073-x. PMID: 30209413.

Donahue SW. Krogh’s principle for musculoskeletal physiology and pathology. J Musculoskelet Neuronal Interact. 2018 Sep 1;18(3):284-91. PMID: 30179205; PMCID: PMC6146200.

Krishnan Y, Grodzinsky AJ. Cartilage diseases. Matrix Biol. 2018 Oct;71-72:51-69. doi: 10.1016/j.matbio.2018.05.005. Epub 2018 May 24. PMID: 29803938; PMCID: PMC6146013.

Swain S, Sarmanova A, Coupland C, Doherty M, Zhang W. Comorbidities in Osteoarthritis: A Systematic Review and Meta-Analysis of Observational Studies. Arthritis Care Res (Hoboken). 2020 Jul;72(7):991-1000. doi: 10.1002/acr.24008. Epub 2020 Jun 7. PMID: 31207113.

Kiadaliri A, Englund M. Trajectory of excess healthcare consultations, medication use, and work disability in newly diagnosed knee osteoarthritis: a matched longitudinal register-based study. Osteoarthritis Cartilage. 2021 Mar;29(3):357-64. doi: 10.1016/j.joca.2020.12.008. Epub 2020 Dec 31. PMID: 33359251.

Menon J, Mishra P. Health care resource use, health care expenditures and absenteeism costs associated with osteoarthritis in US healthcare system. Osteoarthritis Cartilage. 2018 Apr;26(4):480-84. doi: 10.1016/j.joca.2017.12.007. Epub 2017 Dec 18. PMID: 29269328.

Coggon D, Reading I, Croft P, McLaren M, Barrett D, Cooper C. Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord. 2001 May;25(5):622-7. doi: 10.1038/sj.ijo.0801585. PMID: 11360143.

Liu B, Balkwill A, Banks E, Cooper C, Green J, Beral V. Relationship of height, weight and body mass index to the risk of hip and knee replacements in middleaged women. Rheumatology (Oxford). 2007 May;46(5):861-7. doi: 10.1093/rheumatology/kel434. Epub 2007 Feb 4. PMID: 17282995.

Lequesne MG. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol. 1997 Apr;24(4):779-81. PMID: 9101517.

Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988 Dec;15(12):1833-40. PMID: 3068365.

Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol. 1997 May;36(5):551-9. doi: 10.1093/rheumatology/36.5.551. PMID: 9189057.

Downloads

Download data is not yet available.